Tg Therapeutics (TGTX) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to 0.59.
- Tg Therapeutics' Equity Ratio rose 8066.02% to 0.59 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.59, marking a year-over-year increase of 8066.02%. This contributed to the annual value of 0.38 for FY2024, which is 2095.78% down from last year.
- As of Q3 2025, Tg Therapeutics' Equity Ratio stood at 0.59, which was up 8066.02% from 0.39 recorded in Q2 2025.
- In the past 5 years, Tg Therapeutics' Equity Ratio ranged from a high of 0.81 in Q1 2021 and a low of 0.14 during Q1 2023
- Its 5-year average for Equity Ratio is 0.48, with a median of 0.46 in 2022.
- In the last 5 years, Tg Therapeutics' Equity Ratio soared by 620889.79% in 2021 and then crashed by 7527.89% in 2023.
- Tg Therapeutics' Equity Ratio (Quarter) stood at 0.62 in 2021, then crashed by 51.55% to 0.3 in 2022, then skyrocketed by 60.9% to 0.49 in 2023, then decreased by 20.96% to 0.38 in 2024, then skyrocketed by 53.9% to 0.59 in 2025.
- Its last three reported values are 0.59 in Q3 2025, 0.39 for Q2 2025, and 0.36 during Q1 2025.